Retatrutide 10mg

Next-Generation Triple Agonist Peptide for Metabolic Research

Retatrutide 10mg is a high-purity, research-grade peptide being studied for its potential effects on weight management, metabolic health, and glucose regulation. Unlike GLP-1 receptor agonists alone, Retatrutide is a triple hormone receptor agonist that activates GIP (Glucose-Dependent Insulinotropic Polypeptide), GLP–1 (Glucagon-Like Peptide-1), and glucagon receptors. This unique three-pathway mechanism has made it one of the most promising investigational peptides in metabolic research.

Manufactured to high-purity standards, the 10mg formulation is supplied as a lyophilized (freeze-dried) peptide for laboratory research purposes.

Product Highlights

• Peptide: Retatrutide (LY3437943)
• Strength: 10mg per vial
• Category: Triple GIP, GLP-1 & Glucagon Receptor Agonist
• Form: Lyophilized (freeze-dried) peptide powder
• Administration: Reconstituted for subcutaneous injection in research settings
• Quality: High-purity research-grade peptide

What Is Retatrutide Made Of?

Retatrutide is a synthetic 39-amino acid peptide engineered to simultaneously activate the body’s GIP, GLP-1, and glucagon receptors. It incorporates structural modifications that improve stability and extend its duration of action, supporting once-weekly dosing in clinical trials.

What Is Retatrutide Studied For?

Retatrutide is currently being investigated for its potential role in:

• Supporting healthy weight management
• Improving blood glucose control
• Enhancing insulin sensitivity
• Reducing appetite and food intake
• Increasing feelings of fullness (satiety)
• Increasing energy expenditure
• Supporting fat metabolism and fat oxidation
• Improving overall metabolic health
• Investigating obesity and type 2 diabetes treatment

Phase 2 and Phase 3 clinical research has shown substantial weight-loss and metabolic improvements, but the medication is still under investigation and has not yet received FDA approval.

Potential Benefits

• Supports metabolic research
• May promote healthy body weight
• May reduce appetite and cravings
• Supports healthy blood sugar regulation
• May increase calorie expenditure
• High-purity peptide for laboratory research
• Convenient once-weekly dosing schedule in clinical trials

How It Works

Retatrutide works by activating three key hormone receptors involved in metabolism:

• GLP-1 receptors to promote satiety, reduce appetite, and slow gastric emptying.
• GIP receptors to support insulin secretion and glucose regulation.
• Glucagon receptors to increase energy expenditure and promote fat utilization.

The combination of these three mechanisms is being studied for potentially greater metabolic and weight-management effects than therapies targeting only one or two of these pathways.

Storage

• Store the lyophilized vial in a cool, dry place before reconstitution.
• After reconstitution, refrigerate according to laboratory protocol.
• Protect from excessive heat, moisture, and direct light.